Showing 1,621 - 1,640 results of 102,532 for search '(( i ex decrease ) OR ( 5 ((step decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.49s Refine Results
  1. 1621
  2. 1622
  3. 1623
  4. 1624
  5. 1625

    Pharmacokinetic and <i>ex vivo</i> pharmacodynamic properties of anti-C5 antibodies in <i>C5</i><sup><i>hu/hu</i></sup> mice. by Adrianna Latuszek (8816489)

    Published 2020
    “…<p>(A) Serum concentrations of antibodies were measured by ELISA at 6 hours, 1, 2, 3, 7, 10, 13, 21, 30, 45 and 59 days post dosing in <i>C5</i><sup><i>hu/hu</i></sup> mice administered a single 15 mg/kg subcutaneous dose of anti-C5 mAbs or IgG4<sup>P</sup> control antibody (n = 5). …”
  6. 1626
  7. 1627
  8. 1628
  9. 1629
  10. 1630
  11. 1631
  12. 1632
  13. 1633
  14. 1634

    Effect of OKN-007 on the immunoexpression of SULF2 in IC3752 pGBM tumor bearing mice. by Patricia Coutinho de Souza (780490)

    Published 2015
    “…OKN-007 (NR); (4) Normal vs. OKN-007 (R); (5) UT vs. OKN-007 (NR); and (6) Normal vs. OKN-007 (NR).…”
  15. 1635

    Effect of OKN-007 on the immunoexpression of PDGFR-α in IC3752 pGBM tumor bearing mice. by Patricia Coutinho de Souza (780490)

    Published 2015
    “…OKN-007 (NR); (4) Normal vs. OKN-007 (R); (5) UT vs. OKN-007 (NR); and (6) Normal vs. OKN-007 (NR).…”
  16. 1636
  17. 1637
  18. 1638
  19. 1639
  20. 1640